Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-39,200
Closed -$6.75M 614
2017
Q2
$6.75M Sell
39,200
-285,200
-88% -$46.4M 0.26% 48
2017
Q1
$53.2M Buy
324,400
+146,200
+82% +$24.3M 0.38% 32
2016
Q4
$26.1M Sell
178,200
-12,500
-7% -$1.88M 0.12% 133
2016
Q3
$31.8M Sell
190,700
-31,000
-14% -$5.24M 0.15% 105
2016
Q2
$33.7M Buy
221,700
+19,700
+10% +$3.06M 0.16% 115
2016
Q1
$30.3M Buy
202,000
+90,900
+82% +$13.5M 0.15% 108
2015
Q4
$18M Sell
111,100
-186,600
-63% -$29.3M 0.09% 175
2015
Q3
$41.2M Buy
297,700
+29,700
+11% +$4.68M 0.17% 107
2015
Q2
$41.1M Buy
268,000
+26,800
+11% +$4.29M 0.18% 84
2015
Q1
$38.6M Sell
241,200
-5,500
-2% -$866K 0.17% 110
2014
Q4
$39.3M Sell
246,700
-23,500
-9% -$3.66M 0.16% 94
2014
Q3
$38M Sell
270,200
-6,400
-2% -$836K 0.16% 85
2014
Q2
$32.7M Buy
276,600
+14,300
+5% +$1.66M 0.15% 96
2014
Q1
$32.4M Buy
262,300
+62,100
+31% +$7.53M 0.14% 115
2013
Q4
$22.8M Sell
200,200
-249,400
-55% -$28.4M 0.08% 182
2013
Q3
$50.3M Buy
449,600
+86,000
+24% +$9.33M 0.18% 79
2013
Q2
$35.9M Buy
+363,600
New +$37.7M 0.13% 116

Other funds holding AMGN

Timber Hill's AMGN Position: Q2 2018 in Review

Timber Hill sold out of Amgen (AMGN) in Q2 2018, closing a stake of 7,109 shares — an estimated $1.21M sold.

Timber Hill first reported a position in AMGN in Q3 2013 and held it in 10 quarters. The position peaked at $10.5M in Q3 2013. 1,763 funds tracked by Wall St. Rank hold AMGN as of Q2 2018.

  • Timber Hill reported no remaining Amgen position as of Q2 2018 after selling out during the quarter.
  • Timber Hill sold 7,109 Amgen shares in Q2 2018, an estimated $1.21M.
  • Timber Hill first reported a position in Amgen in Q3 2013 and held it in 10 quarters.
  • Timber Hill's Amgen position peaked at $10.5M in Q3 2013.
  • 1,763 funds tracked by Wall St. Rank held Amgen as of Q2 2018.

Based on Timber Hill's 13F filing for Q2 2018, filed 9 Aug 2018.